TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Clinical trials for TRANSTHYRETIN CARDIAC AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN CARDIAC AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN CARDIAC AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to protect transplanted hearts from deadly protein buildup
Disease control Recruiting nowThis study is testing if the drug tafamidis is safe and helpful for people who have already received a heart transplant because of a serious disease called ATTR cardiac amyloidosis. The disease causes harmful proteins to build up and damage organs. Even after a heart transplant, …
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI heart test could spot deadly disease earlier
Diagnosis Recruiting nowThis study is testing a computer program (AI) that analyzes standard heart tracings (ECGs) to see if it can accurately detect a serious heart condition called transthyretin cardiac amyloidosis. The goal is to validate the AI tool's ability to tell the difference between people wh…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC